These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 1271716)
1. [Use of curantyl in combination with potassium-containing preparations in chronic ischemic heart disease]. Vasilevskiĭ VV; Neĭko EM; Debenko MV Klin Med (Mosk); 1976 Feb; 54(2):40-2. PubMed ID: 1271716 [No Abstract] [Full Text] [Related]
2. [Peripheral vasodilators in the treatment of chronic circulatory failure in ischemic heart disease patients]. Lipnitskiĭ TN; Sheverda MG; Otkalenko IuK; Brovko AKh; Bogdanov EA Vrach Delo; 1986 Aug; (8):5-8. PubMed ID: 3776159 [No Abstract] [Full Text] [Related]
3. [Comparative evaluation of the vasodilator effect of kurantil and no-spa in population and twin studies]. Zolotaia RD; Zaslavskaia RM; Lil'in ET Farmakol Toksikol; 1984; 47(3):62-6. PubMed ID: 6376164 [TBL] [Abstract][Full Text] [Related]
4. [Effect of curantyl on hemostasis and rheological properties of the blood in chronic ischemic heart disease]. Turebaev MN Sov Med; 1981; (11):94-6. PubMed ID: 7336251 [No Abstract] [Full Text] [Related]
5. [Secondary prevention of ischemic heart disease]. Khamidov NKh; Dodobaeva MS Klin Med (Mosk); 1991 Jan; 69(1):61-3. PubMed ID: 2023397 [TBL] [Abstract][Full Text] [Related]
6. [Comparative clinical study of 2 coronary dilating agents]. Conte G; Andreola F; Gironi G Minerva Cardioangiol; 1967 Apr; 15(4):284-7. PubMed ID: 5613499 [No Abstract] [Full Text] [Related]
7. [Clinical research on the action of dipyridamole administered alone or with benziodarone in coronary insufficiency]. Rădulescu M Med Interna (Bucur); 1965 Oct; 17(10):1225-9. PubMed ID: 5862277 [No Abstract] [Full Text] [Related]
8. [Effect of curantyl on myocardial contractility and regional blood circulation in patients with ischemic heart disease]. Del'va IuV; Neĭko EM Vrach Delo; 1976 Jun; (6):23-6. PubMed ID: 969452 [No Abstract] [Full Text] [Related]
10. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 1. Epidemiological situation of coronary heart disease]. Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1853-64. PubMed ID: 4480270 [No Abstract] [Full Text] [Related]
15. [Topical aspects and new therapeutic possibilities in coronary heart disease]. Krüger K; Felder K Med Welt; 1966 Jul; 29():1541-50. PubMed ID: 4383297 [No Abstract] [Full Text] [Related]
16. [Clinical aspects of persantin, segontin and trimanyl in the light of the results of experimental studies on the coronary circulation in dogs]. Janicki K; Wcislo W Pol Tyg Lek; 1967 May; 22(21):779-81. PubMed ID: 6040998 [No Abstract] [Full Text] [Related]
17. [Effect of curantil and heparin on indices of microcirculatory and blood oxygen balance in ischemic heart disease]. Denisiuk VI Vrach Delo; 1982; (10):26-9. PubMed ID: 7179876 [No Abstract] [Full Text] [Related]
18. [Current drug therapy of chronic ischemic heart disease]. Metelitsa VI Ter Arkh; 1986; 58(5):132-8. PubMed ID: 2874620 [No Abstract] [Full Text] [Related]
19. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 3. Influence of the duration of therapy and co-medication on the therapeutic result. Secondary effects and discontinuation of therapy]. Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1873-9. PubMed ID: 4155950 [No Abstract] [Full Text] [Related]
20. [Correction of hemodynamic and metabolic disorders in patients with ischemic heart disease]. Bondarenko IP Vrach Delo; 1988 Mar; (3):31-4. PubMed ID: 3394292 [No Abstract] [Full Text] [Related] [Next] [New Search]